Previous study reported that high ERCC1 expression is associated with cisplatin resistance phenotype.14 Cisplatin-based chemotherapy can induce cytotoxicity of cancer cells through forming adducts that cause DNA cross-links. Here, ERCC1 is linked to cancer.